These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 1971332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Immunologic prevention of malaria].
    Wagner WH.
    Med Monatsschr Pharm; 1990 Jul; 13(7):209-15. PubMed ID: 1695990
    [No Abstract] [Full Text] [Related]

  • 3. Molecular parasitology: progress towards the development of vaccines for malaria, filariasis, and schistosomiasis.
    Cryz SJ.
    Experientia; 1991 Feb 15; 47(2):146-51. PubMed ID: 2001716
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vaccines for parasitic diseases.
    Price VL, Kieny MP.
    Curr Drug Targets Infect Disord; 2001 Nov 15; 1(3):315-24. PubMed ID: 12455404
    [Abstract] [Full Text] [Related]

  • 7. Vaccines for human malaria: epidemiological and immunological perspectives.
    Webster HK, Diggs CL, Ballou WR, Chulay JD.
    Southeast Asian J Trop Med Public Health; 1988 Sep 15; 19(3):375-89. PubMed ID: 3064321
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of asexual blood stage malaria vaccines.
    Kidson C.
    Southeast Asian J Trop Med Public Health; 1988 Sep 15; 19(3):391-6. PubMed ID: 3064322
    [No Abstract] [Full Text] [Related]

  • 10. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.
    Good MF, Kumar S, Miller LH.
    Immunol Today; 1988 Nov 15; 9(11):351-5. PubMed ID: 3076406
    [No Abstract] [Full Text] [Related]

  • 11. Antigenic glycans in parasitic infections: implications for vaccines and diagnostics.
    Nyame AK, Kawar ZS, Cummings RD.
    Arch Biochem Biophys; 2004 Jun 15; 426(2):182-200. PubMed ID: 15158669
    [Abstract] [Full Text] [Related]

  • 12. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
    Patarroyo ME, Amador R, Clavijo P, Moreno A, Guzman F, Romero P, Tascon R, Franco A, Murillo LA, Ponton G.
    Nature; 1988 Mar 10; 332(6160):158-61. PubMed ID: 2450281
    [Abstract] [Full Text] [Related]

  • 13. Progress on vaccines against parasites.
    Engers HD, Bergquist R, Modabber F.
    Dev Biol Stand; 1996 Mar 10; 87():73-84. PubMed ID: 8854004
    [Abstract] [Full Text] [Related]

  • 14. Cross-reactivity between antibodies in the sera of individuals with leishmaniasis, toxoplasmosis, and Chagas' disease and antigens of the blood-stage forms of Plasmodium falciparum determined by indirect immunofluorescence.
    Abramo C, Fontes CJ, Krettli AU.
    Am J Trop Med Hyg; 1995 Aug 10; 53(2):202-5. PubMed ID: 7677225
    [Abstract] [Full Text] [Related]

  • 15. Malaria vaccines. Are they approaching reality?
    Perlmann P.
    Nature; 1995 Aug 10; 328(6127):205-6. PubMed ID: 3299105
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Malaria--any hopes?
    Joshi VR, Sainani GS.
    J Assoc Physicians India; 1987 Mar 10; 35(3):181-2. PubMed ID: 3301794
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Research in malaria vaccines.
    Miller LH.
    N Engl J Med; 1986 Sep 04; 315(10):640-1. PubMed ID: 3526149
    [No Abstract] [Full Text] [Related]

  • 20. DNA vaccines for parasitic infections.
    Kalinna BH.
    Immunol Cell Biol; 1997 Aug 04; 75(4):370-5. PubMed ID: 9315480
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.